#
Dr. John Inadomi

Colorectal Cancer Screening, Which Test Is Best?

80% by 2018 is a movement in which hundreds of organizations have committed to eliminating colorectal cancer as a major public health problem. However, there are multiple options available for colorectal cancer screening that vary in accuracy, interval, and harms.

Read More
#
Dr. Sum Lee

The Changing Faces of Cholangitis

The term ‘cholangitis’ taken at face value means inflammation in the biliary system. This simple terminology is deceptive, however, as it encompasses a wide variety of diseases. This review highlights advances in research that point to novel insights into this diverse array of disorders.

Read More
#
Dr. Scott Lee

Reinduction with Certolizumab Pegol in Patients with Crohn’s

Patients with Crohn’s disease, in whom anti-TNF therapy fails, have limited treatment options. Is there benefit to reintroducing the same therapy?

Read More
#
Dr. Anita Afzali

Racial and Ethnic Minorities with IBD in the United States

IBD has predominantly affected whites, particularly Ashkenazi Jews. Over the last 2 decades, IBD has emerged in minorities. Differences in natural history and disease characteristics have been suggested. This systematic review summarizes these differences in studies from the U.S.

Read More
#
Dr. Joo Ha Hwang

Screening and Surveillance for Gastric Cancer: Is It Needed?

The perception of gastric cancer in the US is that it is a relatively uncommon disease and that screening is not needed. However, most people do not realize that gastric cancer is more common than esophageal cancer in the US.

Read More